Nanotechnology in reproductive medicine: Opportunities for clinical translation.

摘要: In recent years, nanotechnology has revolutionized global healthcare and been predicted to exert a remarkable effect on clinical medicine. this context, the use of nanomaterials for cancer diagnosis, fertility preservation, management infertility other pathologies linked pubertal development, menopause, sexually transmitted infections, HIV (human immunodeficiency virus) substantial promise fill existing lacunae in reproductive healthcare. Of late, number trials involving nanoparticles early detection tract infections cancers, targeted drug delivery, cellular therapeutics have conducted. However, most these nanoengineering are still at nascent stage, better synergy between pharmaceutics, chemistry, cutting-edge molecular sciences is needed effective translation interventions from bench bedside. To bridge gap translational outcome product strategic partnerships with insight ability anticipate challenges, as well an in-depth understanding pathways involved, highly essential. Such amalgamations would overcome regulatory gauntlet technical hurdles, thereby facilitating nano-based tools technologies. The present review comprehensively focuses emerging applications nanotechnology, which holds enormous improved diagnosis various human diseases conditions.